Titin’s role in diastolic heart function across species

Antonio de Marvao, Rizwan Ahmed, Ronny Schweitzer, Kathryn A. McGurk, Paolo Inglese, Pierre-Raphaël Schiratti, Soodeh Kalaie, Sean L. Zheng, Saad Javed, Mit Shah, Chang Lu, Vladimir Losev, Deva S Senevirathne, Lara Curran, Pantazis Theotokis, Rachel Buchan, Wenjia Bai, Sebastian Schäfer, Brian P. Halliday, James S. Ware, Stuart A. Cook, Declan P. O’ReganmedRxiv 2025 · DOI

Abstract

Cardiac diastolic function and blood pressure are physiologically interconnected, making it difficult to isolate the genetic determinants of heart relaxation from the effects of systemic loading. This study utilized a cross-species approach, combining quantitative trait locus (QTL) mapping in rats with large-scale human genomic and imaging data from the UK Biobank. In rats, we identified a significant locus on chromosome 3, corresponding to the titin (Ttn) gene, that regulates left ventricular relaxation independently of blood pressure. In humans, rare titin truncating variants (TTNtv) were associated with a significantly increased risk of heart failure (HR 3.76) and impaired diastolic strain rates, even in individuals with normal systolic function. These findings establish titin as a primary genetic driver of diastolic function across species and a potential early marker for heart failure.

Introduction

Heart failure is a complex clinical syndrome often categorized by whether the primary defect lies in the heart's ability to pump blood (systolic function) or its ability to fill with blood (diastolic function). Diastolic dysfunction, characterized by increased myocardial stiffness and impaired relaxation, is a major contributor to heart failure with preserved ejection fraction (HFpEF). However, identifying the specific genetic drivers of diastolic function is challenging because it is "physiologically tangled" with blood pressure; chronic hypertension induces structural changes in the heart that mimic primary genetic stiffness. To address this, researchers sought to decouple these factors using a combination of controlled animal models and high-resolution human biobank data.

Decoupling Function from Pressure in Rat Models

To isolate intrinsic cardiac mechanics from systemic influences, the study employed an ex vivo Langendorff preparation using an F2 intercross of Brown Norway (BN) and Spontaneously Hypertensive Rat (SHR) strains. By perfusing the hearts outside the body, researchers could strictly control heart rate and loading conditions while measuring left ventricular relaxation ($dP/dt_{min}$) and contractility ($dP/dt_{max}$).

Quantitative Trait Locus (QTL) mapping revealed a single significant locus on chromosome 3 that reached genome-wide significance for relaxation. This locus, which encodes the Ttn gene, explained 21.8% of the variation in heart relaxation and 17.2% of the variation in contractility. Crucially, this genetic association remained significant regardless of the animal's baseline blood pressure, identifying titin as a primary regulator of the heart's "intrinsic" relaxation capacity.

Human Clinical Implications and the UK Biobank

The study translated these findings to humans by analyzing Whole Exome Sequencing (WES) data from 454,756 participants in the UK Biobank. The researchers focused on rare Titin Truncating Variants (TTNtv), which were found in approximately 1 in 270 participants (0.37%).

Clinical Outcomes

Carrying a TTNtv was strongly associated with adverse clinical outcomes:

  • Heart Failure: A 3.76-fold increased risk (95% CI: 3.30-4.29).
  • Major Adverse Cardiac Events (MACE): A 1.94-fold increased risk (95% CI: 1.78-2.12).

Subclinical Imaging Phenotypes

Using deep-learning algorithms to analyze Cardiac Magnetic Resonance (CMR) imaging in nearly 34,000 participants, the team identified a "silent" phase of heart disease. TTNtv carriers exhibited significantly lower Peak Early Diastolic Strain Rate (PDSR) across longitudinal, radial, and circumferential directions. Notably, these deficits in relaxation speed were present even in individuals with normal ejection fractions and no evidence of ventricular dilatation, suggesting that diastolic impairment is an early, subclinical marker of genetic heart disease.

The Molecular Spring

Titin is the largest protein in the human body, serving as a structural scaffold and a "molecular spring" within the sarcomere. It provides the passive recoil necessary for the heart to fill efficiently during diastole. This study reinforces the role of titin as a fundamental biological constant in mammalian cardiac mechanics. The fact that natural variations in Ttn affect function in both rats and humans suggests that the protein's mechanical properties are critical to maintaining healthy filling pressures.

Conclusion and Future Directions

This research demonstrates that titin variants impair myocardial relaxation and increase heart failure risk long before clinical symptoms like heart dilation appear. While the study is limited by the primarily European ancestry of the UK Biobank cohort, it opens new doors for therapeutic intervention. Because titin’s stiffness can be modulated by post-translational modifications (such as phosphorylation), future treatments could potentially "tune" the titin spring to alleviate diastolic dysfunction in patients with HFpEF, a condition that currently lacks diverse effective treatment options.

Summary updated

Abstract

Abstract Background Cardiac diastolic function and blood pressure are physiologically tightly interconnected. While diastolic function is regulated by post-translational modifications of sarcomeric genes, including titin ( TTN ), isolating its genetic determinants from those influencing blood pressure is challenging due to variable in vivo loading conditions. We aimed to genetically map diastolic function to the rat genome to prioritise human gene orthologs for genotype-phenotype studies of cardiac function and clinical outcomes. Methods High-fidelity cardiac phenotyping using ex vivo Langendorff preparation in an F2 cross of inbred rat strains included evaluation of left ventricular contractility (LV) (dP / dt max ) and relaxation (dP/dt min ), while controlling loading conditions. In UK Biobank, whole exome sequencing was performed and cardiovascular image-derived phenotypes and outcomes were compared in adult rare variant carriers and genotype-negative participants. Results In rats, quantitative trait locus analysis identified a single locus on chromosome 3 that reached genome-wide significance for LV relaxation (dP/dt min ), which was also associated with variation in LV contractility (dP/dt max ) but not blood pressure. The Ttn gene, which encodes varied non-synonymous single-nucleotide polymorphisms of parental strains, is encoded at the peak of linkage. In humans, the prevalence of rare titin truncating variants (TTNtv) (allele frequency < 0.00004) in 454,756 UK Biobank participants was 0.37% (n = 1,672). Carrying a TTNtv was associated with an increased risk of death or major adverse cardiac events compared to genotype negative controls (hazard ratio: 1.94; 95% confidence interval [CI]: 1.78-2.12; P < 0.001), mainly due to heart failure endpoints (hazard ratio: 3.76; 95% CI: 3.30-4.29; P < 0.001). In 33,988 participants with both cardiac magnetic resonance imaging and whole exome sequencing, TTNtvs were associated with reduced diastolic function, even in participants with normal systolic function and no ventricular dilatation. Conclusions These studies demonstrate for the first time in rats, that naturally occurring variations in Ttn are associated with diastolic function, independently of blood pressure, and in humans TTNtv cause impaired cardiac relaxation and adverse outcomes before overt cardiomyopathy develops.
BibTeX
@misc{marvao2025titins,
  author = {Antonio de Marvao and Rizwan Ahmed and Ronny Schweitzer and Kathryn A. McGurk and Paolo Inglese and Pierre-Raphaël Schiratti and Soodeh Kalaie and Sean L. Zheng and Saad Javed and Mit Shah and Chang Lu and Vladimir Losev and Deva S Senevirathne and Lara Curran and Pantazis Theotokis and Rachel Buchan and Wenjia Bai and Sebastian Schäfer and Brian P. Halliday and James S. Ware and Stuart A. Cook and Declan P. O’Regan},
  title = {{Titin’s role in diastolic heart function across species}},
  year = {2025},
  doi = {10.1101/2025.07.29.25332316},
  howpublished = {medRxiv},
}
Figure